CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 102 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874,442 | +199.8% | 58,648 | +120.2% | 0.00% | – |
| Q2 2023 | $291,686 | -94.1% | 26,638 | -95.3% | 0.00% | -100.0% |
| Q1 2023 | $4,983,471 | +599.1% | 571,499 | +402.7% | 0.00% | – |
| Q4 2022 | $712,792 | +1727.7% | 113,683 | +910.2% | 0.00% | – |
| Q3 2022 | $39,000 | +8.3% | 11,253 | -8.2% | 0.00% | – |
| Q2 2022 | $36,000 | -45.5% | 12,252 | -18.8% | 0.00% | – |
| Q2 2021 | $66,000 | -73.7% | 15,085 | -72.7% | 0.00% | – |
| Q1 2021 | $251,000 | -73.9% | 55,332 | -67.0% | 0.00% | – |
| Q4 2020 | $962,000 | +63.3% | 167,563 | +106.0% | 0.00% | – |
| Q3 2020 | $589,000 | +280.0% | 81,344 | +3.1% | 0.00% | – |
| Q4 2019 | $155,000 | -64.2% | 78,903 | +141.9% | 0.00% | -100.0% |
| Q1 2019 | $433,000 | – | 32,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |